Zeljko Antic

Wuerzburg, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

Journal: Blood
Published: February 13, 2026

clinTALL: machine learning-driven multimodal subtype classification and treatment outcome prediction in pediatric T-ALL.

clinTALL: machine learning-driven multimodal subtype classification and treatment outcome prediction in pediatric T-ALL.

Journal: Genome medicine
Published: December 22, 2025

NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation.

NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation.

Journal: Blood
Published: October 08, 2024

Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia.

Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia.

Journal: Leukemia
Published: June 14, 2024

The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia.

The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia.

Journal: Best practice & research. Clinical haematology
Published: December 05, 2023

An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasia.

An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasia.

Journal: EBioMedicine
Published: September 11, 2023

Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL.

Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL.

Journal: Leukemia
Published: July 07, 2023

The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis.

The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis.

Journal: Blood
Published: May 08, 2023

The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age.

The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age.

Journal: HemaSphere
Published: April 19, 2023

Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia.

Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia.

Journal: Best practice & research. Clinical haematology
Published: March 22, 2023

Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics.

Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics.

Journal: Cancers
Published: October 08, 2021

Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.

Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.

Journal: Pediatric blood & cancer
Published: May 08, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026